Longitudinal Analysis of Estrogen Receptor Gene Methylation, Estradiol, and Depressive Symptoms During the Perinatal Period

DNA methylation of estrogen receptor genes (ESR1, ESR2, and GPER) may affect the expression of the estrogen receptors (ERs) alpha, beta, and G protein-coupled estrogen receptor (GPER). Altered receptor expression may in turn affect the receptors' sensitivity to estrogen, thereby modulating vulnerability to depression during periods of estrogen fluctuation. The aim of this study was to investigate the association between the methylation of ESR1, ESR2, and GPER, depressive symptoms, and estradiol during the perinatal period using a longitudinal design. A total of 159 women were followed longitudinally from 34 to 36 weeks of gestation to 8-12 weeks postpartum. Depressive symptoms were assessed using the Edinburgh Postnatal Depression Scale (EPDS). Salivary estradiol levels were quantified, and DNA methylation was analyzed using dried blood spots. Multivariate linear regressions and paired t-tests were used for analysis. Depressive symptoms were negatively associated with the mean overall ESR1 methylation during pregnancy (β = -0.41, p = 0.002), but not during the postpartum period (p ≥ 0.05). Haplotype CA during pregnancy (p ≤ 0.001) and haplotype TA (p = 0.03) during postpartum modified the relationship between depressive symptoms and overall mean ESR1 DNAm. No associations emerged for ESR2, GPER, or estradiol at either time point (all p ≥ 0.05). The mean overall methylation of ESR1 increased from pregnancy to postpartum (t = -2.59, p = 0.012) and was positively associated with depressive symptom scores during pregnancy (β = 0.418, p = 0.031). This work suggests that lower DNA methylation levels of ESR1, which may reflect higher ER-alpha expression and thus greater sensitivity to estrogen, are associated with increased depressive symptoms during pregnancy. The findings highlight molecular pathways of estrogen sensitivity, particularly via ER-alpha, as a promising target for future biomarker research for perinatal depression.

Authors

Institutions

Publication Details

Journal
Molecular Neurobiology
Published
2025-12-01
DOI
https://doi.org/10.1007/s12035-025-05556-3
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Longitudinal Analysis of Estrogen Receptor Gene Methylation, Estradiol, and Depressive Symptoms During the Perinatal Period

Alexandra Johann, Elena Gardini, Ulrike Ehlert, Jelena Đukić et al.
Molecular Neurobiology
Menopause: Health Impacts and Treatments
article

Longitudinal Analysis of Estrogen Receptor Gene Methylation, Estradiol, and Depressive Symptoms During the Perinatal Period

Alexandra Johann, Elena Gardini, Ulrike Ehlert, Jelena Đukić, Gianna Zorzini
article en

Abstract

DNA methylation of estrogen receptor genes (ESR1, ESR2, and GPER) may affect the expression of the estrogen receptors (ERs) alpha, beta, and G protein-coupled estrogen receptor (GPER). Altered receptor expression may in turn affect the receptors' sensitivity to estrogen, thereby modulating vulnerability to depression during periods of estrogen fluctuation. The aim of this study was to investigate the association between the methylation of ESR1, ESR2, and GPER, depressive symptoms, and estradiol during the perinatal period using a longitudinal design. A total of 159 women were followed longitudinally from 34 to 36 weeks of gestation to 8-12 weeks postpartum. Depressive symptoms were assessed using the Edinburgh Postnatal Depression Scale (EPDS). Salivary estradiol levels were quantified, and DNA methylation was analyzed using dried blood spots. Multivariate linear regressions and paired t-tests were used for analysis. Depressive symptoms were negatively associated with the mean overall ESR1 methylation during pregnancy (β = -0.41, p = 0.002), but not during the postpartum period (p ≥ 0.05). Haplotype CA during pregnancy (p ≤ 0.001) and haplotype TA (p = 0.03) during postpartum modified the relationship between depressive symptoms and overall mean ESR1 DNAm. No associations emerged for ESR2, GPER, or estradiol at either time point (all p ≥ 0.05). The mean overall methylation of ESR1 increased from pregnancy to postpartum (t = -2.59, p = 0.012) and was positively associated with depressive symptom scores during pregnancy (β = 0.418, p = 0.031). This work suggests that lower DNA methylation levels of ESR1, which may reflect higher ER-alpha expression and thus greater sensitivity to estrogen, are associated with increased depressive symptoms during pregnancy. The findings highlight molecular pathways of estrogen sensitivity, particularly via ER-alpha, as a promising target for future biomarker research for perinatal depression.

Molecular NeurobiologyVol. 63(1)
University of Zurich (CH)
National Science Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Eidgenössische Technische Hochschule Zürich, Universität Zürich
Openalex Percentile: Top 50%
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.